• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGT2610
Device Problem Therapy Delivered to Incorrect Body Area (1508)
Patient Problem No Code Available (3191)
Event Date 11/27/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient was to be implanted with a gore® tag® thoracic endoprosthesis (item#: tgt2610, lot#:11722078) for treatment of a thoracic aortic aneurysm.The tag® device was advanced though a 20fr gore® dryseal sheath (item#:sdv2028, lot#:12837316).According to the report, the tag® device automatically and unintentionally deployed at a location other than intended during advancement.No branch vessels were covered by the deployed device.According to the physician, the unintentional deployment may have been caused by excessive calcification.After considering the patient¿s calcified anatomy and the duration of spinal anaesthesia, the physician opted to end the procedure.
 
Manufacturer Narrative
The review of the manufacturing records verified that this lot met all pre-release specifications.Per the gore® tag® thoracic endoprosthesis instructions for use (ifu), w.L.Gore & associates recommends additional considerations for patient selection before use of the gore® tag® thoracic endoprosthesis include but are not limited to that the morphology (minimal thrombus, calcium and / or tortuosity) should be compatible with vascular access techniques and accessories.
 
Manufacturer Narrative
(b)(4).Per the gore® tag® thoracic endoprosthesis instructions for use (ifu), complications associated with the use of the gore® tag® thoracic endoprosthesis may include but are not limited to: endoprosthesis: improper placement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
helen huang
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4372622
MDR Text Key5288561
Report Number2017233-2014-00683
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2016
Device Catalogue NumberTGT2610
Device Lot Number11722078
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/30/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age68 YR
Patient Weight50
-
-